Previous Article | Next Article 
Molecular and Cellular Biology, June 2000, p. 4275-4287, Vol. 20, No. 12
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Disruption of the 11-cis-Retinol
Dehydrogenase Gene Leads to Accumulation of cis-Retinols and
cis-Retinyl Esters
Carola A. G. G.
Driessen,1,*
Huub J.
Winkens,1
Kirstin
Hoffmann,2
Leonoor D.
Kuhlmann,1
Bert P. M.
Janssen,1
Anke H. M.
Van
Vugt,1
J. Preston
Van
Hooser,3
B. E.
Wieringa,4
August F.
Deutman,1
Krzysztof
Palczewski,3,5,6
Klaus
Ruether,2 and
Jacques
J. M.
Janssen1
Department of Ophthalmology, University of Nijmegen, 6525 EX Nijmegen, The Netherlands1;
Department of Ophthalmology, Humboldt University, 15553 Berlin,
Germany2; Departments of
Ophthalmology,3
Chemistry,5 and
Pharmacology,6 University of
Washington, Seattle, Washington 98195; and Department of Cell
Biology, University of Nijmegen, 6500 HB Nijmegen, The
Netherlands4
Received 28 January 2000/Accepted 13 March 2000
 |
ABSTRACT |
To elucidate the possible role of 11-cis-retinol
dehydrogenase in the visual cycle and/or 9-cis-retinoic
acid biosynthesis, we generated mice carrying a targeted disruption of
the 11-cis-retinol dehydrogenase gene. Homozygous
11-cis-retinol dehydrogenase mutants developed normally,
including their retinas. There was no appreciable loss of
photoreceptors. Recently, mutations in the 11-cis-retinol dehydrogenase gene in humans have been associated with fundus albipunctatus. In 11-cis-retinol dehydrogenase knockout
mice, the appearance of the fundus was normal and punctata typical of this human hereditary ocular disease were not present. A second typical
symptom associated with this disease is delayed dark adaptation. Homozygous 11-cis-retinol dehydrogenase mutants showed
normal rod and cone responses. 11-cis-Retinol dehydrogenase
knockout mice were capable of dark adaptation. At bleaching levels
under which patients suffering from fundus albipunctatus could be
detected unequivocally, 11-cis-retinol dehydrogenase
knockout animals displayed normal dark adaptation kinetics. However, at
high bleaching levels, delayed dark adaptation in
11-cis-retinol dehydrogenase knockout mice was noticed.
Reduced 11-cis-retinol oxidation capacity resulted in
11-cis-retinol/13-cis-retinol and
11-cis-retinyl/13-cis-retinyl ester
accumulation. Compared with wild-type mice, a large increase in the
11-cis-retinyl ester concentration was noticed in
11-cis-retinol dehydrogenase knockout mice. In the murine
retinal pigment epithelium, there has to be an additional mechanism for
the biosynthesis of 11-cis-retinal which partially
compensates for the loss of the 11-cis-retinol
dehydrogenase activity. 11-cis-Retinyl ester formation is
an important part of this adaptation process. Functional consequences of the loss of 11-cis-retinol dehydrogenase activity
illustrate important differences in the compensation mechanisms between
mice and humans. We furthermore demonstrate that upon
11-cis-retinol accumulation, the 13-cis-retinol
concentration also increases. This retinoid is inapplicable to the
visual processes, and we therefore speculate that it could be an
important catabolic metabolite and its biosynthesis could be part of a
process involved in regulating 11-cis-retinol
concentrations within the retinal pigment epithelium of
11-cis-retinol dehydrogenase knockout mice.
 |
INTRODUCTION |
Upon illumination of rhodopsin, the
chromophore 11-cis-retinal is isomerized to
all-trans-retinal, which is subsequently released from the
protein. Enzymes involved in the regeneration of
11-cis-retinal are part of the visual cycle (28).
Two redox reactions are known to play a role in this cycle
(48). One of these reactions is the reduction of
all-trans-retinal to all-trans-retinol, catalyzed by retinol dehydrogenases present in the photoreceptor cells. A second
reaction is the oxidation of 11-cis-retinol to
11-cis-retinal in the retinal pigment epithelium (RPE).
Simon and coworkers and we previously reported the cloning of a retinol
dehydrogenase highly expressed in the RPE (4, 37, 38).
Recombinant retinol dehydrogenase catalyzes stereospecific oxidation of 11-cis-retinol but not
all-trans-retinol. The enzyme, which belongs to the
superfamily of short-chain alcohol dehydrogenases, was referred to as
11-cis-retinol dehydrogenase (11-cis-RoDH). Recently, two additional short-chain alcohol dehydrogenases were cloned
that recognize 11-cis-retinol as a substrate, called CRAD1 and CRAD2 (cis-retinol/androgen dehydrogenase type 1 and
type 2, respectively) (2, 41). These enzymes are expressed
at high levels in the liver and at low levels in the RPE. CRAD1 is also
highly expressed in the kidney. Like CRAD1 and CRAD2, expression of
11-cis-RoDH is also widely distributed, because
11-cis-RoDH transcripts were detected in several other
ocular and nonocular tissues in adults (6, 22, 42). Mouse
embryos at gestation day 10-11 also display a broad expression pattern
of 11-cis-RoDH (32). This raises questions about
the relative significance of these three enzymes in the visual cycle
and their functional role in general retinoid metabolism elsewhere.
Several independent studies have shown that recombinant
11-cis-RoDH mediates the oxidation of 9-cis and
13-cis isomers of retinol (6, 22, 35, 42). Moreover, 11-cis-RoDH was found to be able to use
5
-androstan-3
, 17
-diol, and andosterone as substrates
(42), suggesting that 11-cis-RoDH may have a
broader biological significance than anticipated originally.
In the last decade, many proteins have been identified which
cause retinal degeneration. Among these are proteins that
function in the phototransduction cascade, have a structural
role in the rod photoreceptor, or are involved in retinoid
metabolism (serum retinol-binding protein, cellular
retinaldehyde-binding protein, and RPE65) (8, 18, 21, 24,
36; for an overview, see Retnet at
www.sph.uth.tmc.edu). Mice in which those genes were disrupted
have compromised retinal structures and functions (9, 16,
17, 31, 44, 47). Recently, mutations in the
11-cis-RoDH gene were found in two patients with fundus
albipunctatus (46). Here we report on the generation
and characterization of a mouse model in which the
11-cis-RoDH gene is disrupted. Novel data were obtained that
support a role for this enzyme in the visual cycle and unravel an
interesting compensatory mechanism in mouse eyes that partially
compensates for the lack of 11-cis-RoDH gene product.
 |
MATERIALS AND METHODS |
Construction of the targeting vector.
The murine
11-cis-RoDH gene was isolated from a 129/Sv mouse genomic
library (6). A restriction map of the gene is shown in Fig.
1. A multiple cloning site containing
NotI, NheI, EcoRI, SalI,
KpnI, BamHI, and HindIII
restriction sites was subcloned into the pgem13zf(+) vector (Promega,
Leiden, The Netherlands). A 2.6-kb EcoRI fragment spanning
the 11-cis-RoDH gene from
3155 to
568 was cloned into
the BamHI site, while a second fragment of the
11-cis-RoDH gene, spanning from +1955 to +5728, was cloned into the KpnI site. The 1.2-kb neomycin resistance gene
cassette was isolated as an XhoI fragment and cloned into
the vector using the SalI site. Homologous recombination
would result in elimination of the
568 to +1955 region of the
11-cis-RoDH gene, which includes exons I, II, and III of
this gene. Another gene, called GCN5L1, is present upstream
(637 nucleotides) of the 11-cis-RoDH gene (5).
The GCN5L1 gene was not affected by the described targeting disruption strategy. The targeting vector was linearized with NotI.

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 1.
Gene targeting of the murine 11-cis-RoDH
gene. (A) Genomic structures of the murine 11-cis-RoDH
(roman numbers) and GCN5L1 (arabic numbers) genes (upper
panel), structure of the targeting vector (middle panel), and genomic
structure of the targeted 11-cis-RoDH gene (lower panel).
Homologous recombination results in the replacement of exons I, II, and
III of the 11-cis-RoDH gene by a neomycin cassette (NEO).
Positions of the 5' and 3' probes are indicated. Asterisks mark
positions of the primers used for PCR genotype analysis. Abbreviations:
B, BamHI; E, EcoRI; K, KpnI; N,
NheI; S, SstI; HSVtk, herpes simplex virus
thymidine kinase gene. (B) Southern blot analysis of the cell lines.
Autoradiograms of three Southern blots containing genomic DNA from
three targeted ES cell lines and from mouse strain 129/Sv after
hybridization with the 5' probe (left), 3' probe (middle), or
neo probe (right). Sizes are shown in kilobases. (C) PCR
genotyping of mouse tail DNA. PCR fragments derived from wild-type
(11-cis-RoDH+/+), heterozygous
(11-cis-RoDH+/ ), and homozygous
(11-cis-RoDH / ) mice. Offspring were analyzed
with primers KORDH-s1 and neo-a1. The presence of a targeted allele
results in the amplification of a 365-bp fragment (left panel).
Offspring from 11-cis-RoDH+/ parents were
analyzed with primers KORDH-s1 and KORDH-a1, which results in fragments
of 2.9 kb in 11-cis-RoDH+/+ mice, 1.5 and 2.9 kb
in 11-cis-RoDH+/ mice, and 1.5 kb in
11-cis-RoDH / mice (right panel).
|
|
Generation of chimeric mice.
Embryonic stem (ES) cells
(129/Sv) were cultured on irradiated SNLH9 feeder cell layers. After
electroporation of the targeting vector, cells were cultured in
selective medium containing 350 µg of neomycin (G418) per ml and 0.2 µM FIAU. To check appropriate targeting, Southern blot analysis were
performed. A 1.2-kb NheI fragment flanking the 5' end of the
targeting vector was used as a probe to detect a 9.2-kb
BamHI fragment derived from the wild-type allele and a
6.1-kb BamHI fragment from the targeted allele. The
3'-flanking region was checked using a 0.6-kb probe (obtained by
genomic PCR with the upstream primer 5'-TGAGAATTCCTAGTTGGC-3' and downstream primer 5'-TTTTCAATTAAACGGATT-3'), which
detected a 9.5-kb SstI fragment derived from the wild-type
allele and an 8.2-kb SstI fragment from the targeted allele.
Before microinjection, selected ES cell lines were subjected to
karyotype analysis. Three cell lines were finally used for
microinjection into 3.5-day-old C57BL/6 mouse blastocysts. Injected
blastocysts were implanted into pseudopregnant C57BL/6 foster mothers.
Chimeric male mice were mated with C57BL/6 females. Agouti offspring
were analyzed for heterozygous pups by Southern blot analysis (as
described above) or PCR. For PCR analysis, two primers, KORDH-s1
(5'-GGGCAGCTGCAGTCTGCACCATC-3', upstream primer located in
exon IV of the GCN5L1 gene), and neo-a1 (5'-GCCCCGACTGCATCTGCGTGTT-3', downstream primer located in
the neomycin cassette) were used. The presence of a targeted allele was
revealed by amplification of a 365-bp fragment. Heterozygotes were
crossed to generate wild-type (11-cis-RoDH+/+),
heterozygous (11-cis-RoDH+/
), and homozygous
(11-cis-RoDH
/
) offspring. These three
genotypes were also characterized by PCR. For PCR analysis, two
primers, KORDH-s1 and KORDH-a1 (5'-GGGCAAGACCTGACCTGGGGGC-3', located in intron III of the 11-cis-RoDH gene) were
used. From the targeted allele, a 1.5-kb fragment was amplified, while
from the wild-type allele a 2.9-kb fragment was amplified.
11-cis-RoDH RT-PCR.
For reverse
transcriptase-PCR (RT-PCR), total RNA was isolated from whole eyes and
kidneys of 11-cis-RoDH+/+,
11-cis-RoDH+/
, and
11-cis-RoDH
/
mice and subsequently reverse
transcribed to obtain cDNA. The primer sets used in these
procedures are: 11-cis-RoDH, sense
(5'-ATGTGGCTGCCTCTGCTTCT-3') and antisense
(5'-CCAGAGCAGCTTGGCATCCC-3') or sense
(5'-TTCTTTCGAACCCCTGTGAC-3') and antisense
(CCAGAGCAGCTTGGCATCCC-3'); opsin, sense
(5'-GTCGGCTGGTCCAGGTAC-3') and antisense
(5'-GCCACAGCAGAGAGTGGTG-3'); and actin, sense
(5'-ATGGGTCAGAAGGACTCCTA-3') and antisense
(5'-TTGATGTCACGCACGATTTC-3'). Product sizes were 0.9 and
0.25 kb for 11-cis-RoDH, respectively, 0.25 kb for opsin, and 0.5 kb for actin.
Rhodopsin assay.
Mice were dark adapted for 16 h. All
further experiments were performed under dim red light. Mice were
killed, and their eyes were removed. Each eye was homogenized in 2 ml
of phosphate-buffered saline (PBS, pH 7.4). Homogenates were
centrifuged at 145,000 × g and 4°C for 20 min, and
the pellets were resuspended in 1 ml of 1% Triton X-100-PBS. Samples
were incubated for 1 h at 4°C and subsequently centrifuged at
145,000 × g and 4°C for 20 min. Supernatants were
analyzed by UV/VIS spectroscopy. Before the absorbance spectra were
measured, 20 µM hydroxylamine (pH 6.5) was added to each sample. To
quantitate the amount of rhodopsin, a dark spectrum from 700 to 250 nm
was recorded first. To obtain a bleached spectrum, samples were
illuminated for 5 min with a 100-W light bulb at a distance of 10 cm.
Prior to illumination, samples were placed behind a KG1 heat filter
(Schott, Mainz, Germany). Difference spectra (illuminated spectrum
subtracted from the dark spectrum) were used for accurate
quantification of the rhodopsin content per eye using an extinction
coefficient of 42,000 mol/liter per cm.
Retinoid extraction and analysis.
Retinoid analysis was
performed under dim red light as described previously with some
modifications (29). In brief, dark-adapted animals were kept
in the dark for 16 h, whereas light-adapted animals were kept in
the dark for 16 h and subsequently exposed to light (200 cd/m2) for 90 min in their cages. Animals were sacrificed
by cervical dislocation. Eyes were collected, snap frozen in
foil-wrapped Eppendorf tubes on dry ice-ethanol, and stored at
80°C. Anterior segments of collected eyes were removed, and the
remaining, still-frozen, posterior segments were homogenized with 1 ml
of 0.1 M MOPS (morpholinepropanesulfonic acid, pH 6.5) containing 10 mM
NH2OH and 0.2% sodium dodecyl sulfate (SDS).
3H-labeled all-trans-retinol (200,000 dpm) was
added in order to determine the extraction yield of retinoids. The
suspension was homogenized ~10 times and incubated for 30 min at room
temperature to convert retinals to oximes. For retinoid extraction, the
suspension was mixed with 1 ml of absolute ethanol and 4 ml of hexane.
Suspensions were shaken vigorously at room temperature for 2 min, and
phase separation was subsequently achieved by centrifugation (4,000 rpm, 5 min, 4°C). The upper phase was collected, and the extraction was repeated on the lower phase. Extracted retinoids were dried under
argon and resolved in 300 µl of hexane at room temperature.
Retinoid analysis was performed on an HP 1100 series high-pressure
liquid chromatograph (HPLC) equipped with a diode array
detector and HP
Chemstation A.04.05 software, allowing identification
of retinoid
isomers according to their specific retention time
and absorption
maxima. A normal-phase, narrow-bore column (Alltech
Silica 5u Solvent
Miser, 2.1 by 250 mm) and an isocratic solvent
composed of 4% ethyl
acetate in hexane at a flow rate of 0.5 ml/min
were used to separate
retinyl esters from 11-
cis-retinal,
all-
trans-retinal,
11-
cis-retinol, and
all-
trans-retinol at room temperature. Retinyl
esters were
collected and saponified to determine the isomeric
composition of the
ester pool. The solvent from HPLC fractions
encompassing the retinyl
esters (typically 500 µl) was evaporated
under argon. Retinyl esters
were dissolved in 230 µl of absolute
ethanol and hydrolyzed with 20 µl of 6 M KOH for 30 min at 55°C.
To extract the products, the
sample was diluted with 100 µl of
water, chilled on ice for 2 min,
and extracted with 300 µl of
hexane. Hydrolyzed extracted retinoids
were analyzed directly
by HPLC as described above.
11-
cis-Retinol and 13-
cis-retinol
were separated
on a Beckman Ultrasphere Silica 5u column with
1.5% dioxane in hexane
at a flow rate of 1.4 ml/min at 20°C. 11-
cis-
and
13-
cis-retinol were eluted after ~43 and ~45 min,
respectively.
To determine spontaneous isomerization of retinols, we
spiked
RPE bovine membranes with isomerically pure retinols. Spiked
membranes
were incubated for 30 min to allow formation of retinyl
esters.
The esters were extracted and subjected to a procedure similar
to that described above in order to determine the extent of nonspecific
isomerization due to sample handling. These control experiments
showed
that under the conditions used to determine the isomeric
composition of
retinyl esters mentioned above, ~16% of the added
11-
cis-retinol isomerizes to 13-
cis- and ~33%
isomerizes to all-
trans-retinol.
ERG recordings.
Electroretinograms (ERGs) were recorded on
11-cis-RoDH+/+,
11-cis-RoDH+/
, and
11-cis-RoDH
/
mice (six of each) at the age
of 3 months. Anesthesia was induced by subcutaneous injection of 20 mg
of xylazine plus 40 mg of ketamine per kg of body weight. Pupils were
dilated with 1% atropine and 0.5% tropicamide. ERGs were recorded
using a monopolar electrode with a plastic speculum and an embedded
wire loop (diameter, 3 mm) and two subcutaneously applied silver
needles: 3 mm below the eye as a reference and in the forehead as a
ground electrode. Methylcellulose was put on the plastic speculum in
order to obtain a tight connection between electrode and eye. Each
mouse was placed in a Ganzfeld bowl (Toennies Multiliner Vision,
Hoechberg, Germany). Signals were digitized at a rate of 1.7 kHz. The
Ganzfeld stimulus was characterized by a duration of ~50 µs and a
white flash color temperature of 6,000 K.
For scotopic ERGs, mice were dark adapted for 2 h. The flash
intensities used ranged from 4 × 10
4 to 2.5 cd
m
2, divided into eight steps of 0.4 or 0.6 log cd
m
2. At the four lower intensities, five responses were
averaged
(interstimulus interval, 2 s), whereas at higher
intensities two
responses were recorded (interstimulus interval, 5 s). Immediately
after the scotopic ERG recordings, mice were exposed to
a background
light of 30 cd m
2 for 10 min in order to
obtain photopic ERGs. A single flash response
was obtained with 15 cd
m
2 (digitizing rate, 2.56 kHz; gain, 25,000; average,
16).
For dark adaptation ERGs, two approaches were applied. The first
approach was characterized by conditions under which human
patients
suffering from fundus albipunctatus could be detected
unequivocally.
The mice were dark-adapted for 2 h. Subsequently
the maximal
scotopic ERG response was recorded using a 100-mcd
m
2
stimulus. Bleaching was obtained using 100 cd of white light
per m
2 for 2 min. Over a 20-min period, the ERG response was
recorded
every minute using a flash intensity of 100 mcd
m
2. The responses were not averaged to avoid light
adaptation. In
a second experimental setup, we wanted to bleach a much
higher
amount of rhodopsin. After a 16-h period of dark adaptation, an
ERG response using a 100-mcd m
2 stimulus was recorded.
The animals were subsequently exposed
to 800 cd m
2 for 10 min. Experimental conditions are partly derived from those
described
previously for analysis of dark adaptation kinetics
in rhodopsin
transgenic mice (
7). After the light had been
turned off,
the 100-mcd m
2 stimulus was delivered every 3 min. The
endpoint of observation
was set at 45 min because a single maximal dose
of anesthesia
was given, allowing us to keep the animals sedated for
1 h. All
procedures adhered to the standards set by the animal
ethics committee
of the Humboldt University in Berlin. The criterion
for successful
dark adaptation for
11-
cis-RoDH
+/+ mice was defined as the time
point when reproducible ERG responses
comparable to the prebleach
recording could be observed or was
set at 45 min for
11-
cis-RoDH
/
mice. For statistical analysis
of the ERG data on single cone
responses and also for the time point
analysis of the dark adaptation,
the
t test was
applied.
 |
RESULTS |
Construction of 11-cis-RoDH knockout mice.
The
strategy used to target and inactivate the 11-cis-RoDH gene
by replacement of exons 1 to 3 is outlined in Fig. 1A. ES cells that
had undergone a correct targeting event were identified by examining
213 G418-resistant clones by Southern blot analysis (Fig. 1B). Three
cell lines with a normal karyotype were selected for use in blastocyst
injection and embryo transfer into foster mothers. Among the offspring,
five chimeric males (20 to 60% Agouti coat color) and three
chimeric females (20 to 30% Agouti coat color) were identified. Germ
line-transmitting males were selected by following segregation of
the mutant allele with PCR (Fig. 1C). Heterozygous offspring were
interbred to generate wild-type
(11-cis-RoDH+/+), heterozygous
(11-cis-RoDH+/
), and homozygous
(11-cis-RoDH
/
) mice. The offspring were
genotyped using a second PCR strategy, allowing identification of three
genotypes in a single assay (Fig. 1C).
Analysis of 11-cis-RoDH expression.
RT-PCR
analysis were performed on total RNA isolated from whole eyes or
kidneys of 11-cis-RoDH+/+,
11-cis-RoDH+/
, and
11-cis-RoDH
/
mice. No
11-cis-RoDH transcript was detected in RNA isolated from
eyes and kidneys of 11-cis-RoDH
/
mice. A
control transcript,
-actin, was amplified, as anticipated (Fig.
2A to C). Using RNA isolated from the
eyes of 11-cis-RoDH
/
mice, we were able to
amplify the opsin transcript. RT-PCR results were confirmed at the
protein level by Western blot analysis (Fig. 2D and E), which clearly
detected 11-cis-RoDH protein in extracts derived from the
eyes of 11-cis-RoDH+/+ and
11-cis-RoDH+/
mice but not in ocular protein
extracts of 11-cis-RoDH
/
mice
(10).


View larger version (3568K):
[in this window]
[in a new window]
|
FIG. 2.
RT-PCR and Western blot analysis. (A to C) Total RNA was
isolated from the eyes (A and B) and kidney (C) of
11-cis-RoDH / mice (lanes 1 and 5),
11-cis-RoDH+/ mice (lanes 2 and 6), and
11-cis-RoDH+/+ mice (lanes 3 and 7). Primers
specific for 11-cis-RoDH, opsin, and actin were used. The
11-cis-RoDH transcript is absent in
11-cis-RoDH / mice. Actin and opsin
transcripts are present. No products were amplified when template cDNA
was omitted (lanes 4 and 8). Lanes M, Clon16.1.1 size markers or 100-bp
DNA ladder. (D and E) For Western blot analysis, 5 µg of 1% Triton
X-100-PBS-extractable ocular protein from an
11-cis-RoDH+/+ mouse,
11-cis-RoDH+/ mouse, and
11-cis-RoDH / mouse was electrophoresed
on an SDS-13.7% polyacrylamide-tricine gel and transferred to
nitrocellulose. Blots were incubated with a monoclonal antibody against
11-cis-RoDH (D) or opsin (E). Sizes are shown in
kilodaltons.
|
|
Retinal structure, rhodopsin content, and fundus appearance.
To investigate the role of 11-cis-RoDH in retinal
development, eyes from 7-day-old animals were used for histology (Fig.
3A and B). The thickness of the retina
appeared to be the same in all three genotypes. Moreover, all retinal
layers were present in both 11-cisRoDH+/
and
11-cis-RoDH
/
mice. At the light-microscopic
level, no disturbances within the retina were observed when
11-cis-RoDH+/
and
11-cis-RoDH
/
mice were compared with
11-cis-RoDH+/+ animals. Immunohistochemistry
showed the presence of 11-cis-RoDH in the RPE of
11-cis-RoDH+/+ and
11-cis-RoDH+/
mice, while
11-cis-RoDH was absent in
11-cis-RoDH
/
mice (data not shown). The eyes
of 2-, 6-, and 9-month-old animals were examined to analyze a possible
role of 11-cis-RoDH in retinal degeneration. No differences
between the three genotypes were observed at the age of 2 months (Fig.
3C and D) and 6 months (Fig. 3E and F). There was also no indication of
retinal pathology at the age of 9 months (data not shown).

View larger version (73K):
[in this window]
[in a new window]
|
FIG. 3.
Retinal morphology. Retinal sections were obtained from
11-cis-RoDH / (A, C, and E) and
11-cis-RoDH+/+ (B, D, and F) mice aged 7 days (A
and B), 2 months (C and D), and 6 months (E and F). RPE, retinal
pigment epithelium; ROS, rod outer segment; RIS, rod inner segment;
ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner
nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer.
|
|
The eyes of dark-adapted 11-
cis-RoDH
+/+,
11-
cis-RoDH
+/
, and
11-
cis-RoDH
/
mice contained 0.58 ± 0.05, 0.57 ± 0.05, and 0.59 ± 0.03 nmol
of rhodopsin per
eye, respectively. Additionally,
11-
cis-RoDH
+/+,
11-
cis-RoDH
+/
, and
11-
cis-RoDH
/
mice were placed under
constant light (200 cd/m
2 for 90 min). Three animals were
sacrificed at the end of this
period. The remaining animals were placed
in the dark for 5, 60,
and 120 min. The data presented in Fig.
4 show that maximal rhodopsin
levels were
reached by all three genotypes within a 60-min period.
These studies
suggested that the rate of rhodopsin recovery in
11-
cis-RoDH
+/+ mice was somewhat faster
than in 11-
cis-RoDH
/
mice. However, we never
observed a significant difference between
the regeneration rates of
11-
cis-RoDH
+/+ (7.5 ± 1.5 pmol/min),
11-
cis-RoDH
+/
(5.3 ± 1.9 pmol/min), and
11-
cis-RoDH
/
(5.5 ± 1.4 pmol/min)
mice.

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 4.
Bleaching and recovery of rhodopsin.
11-cis-RoDH+/+ (open bars),
11-cis-RoDH+/ (solid bars), and
11-cis-RoDH / (hatched bars) mice were given
continuous light with an intensity of 200 cd/m2 for 90 min.
Following this light period, ±65% of the visual pigment was bleached.
Animals that were dark-adapted for 16 h were found to contain
0.58 ± 0.05 (11-cis-RoDH+/+, mean ± SD, n = 3), 0.57 ± 0.05 (11-cis-RoDH+/ , mean ± SD, n = 3), and 0.59 ± 0.03 (11-cis-RoDH / , mean ± SD, n = 3) nmol of rhodopsin per eye. Data presented show that that
these levels are reached by all three genotypes tested within a 60-min
period. Under these conditions there is no clear difference between the
regeneration rates of 11-cis-RoDH+/+ (7.5 ± 1.5 pmol/min), 11-cis-RoDH+/ (5.3 ± 1.9 pmol/min), and 11-cis-RoDH / (5.5 ± 1.4 pmol/min) mice.
|
|
Fundus albipunctatus belongs to a group of retinopathies characterized
by a flecked retina. To investigate whether
11-
cis-RoDH
/
mice also have white punctata
present in their fundus, video
ophthalmoscopy was performed with a
scanning laser ophthalmoscope.
There was no difference between the
fundus of 11-
cis-RoDH
+/+ and
11-
cis-RoDH
/
mice. As an example, Fig.
5A and B show two fundus photographs
of
2-month-old 11-
cis-RoDH
+/+ and
11-
cis-RoDH
/
mice, respectively. The retinal
pigment epithelia are smooth,
blood vessels show no irregularities and,
moreover, no white punctata
are present.

View larger version (100K):
[in this window]
[in a new window]
|
FIG. 5.
Scanning laser ophthalmoscope photographs of
11-cis-RoDH+/+ (A) and
11-cis-RoDH / (B) mice at the age of 2 months.
|
|
Retinoid analysis.
The animals used in these studies were
housed under 12-h dark conditions and were ~3 months old. Before the
eyes were collected for retinoid analysis, mice were dark adapted for
16 h. Three animals were sacrificed in the dark (dark adapted) and
three received 200 cd/m2 for 90 min (light adapted). The
posterior segments of these eyes were collected and prepared for
retinoid analysis.
In Fig.
6, typical HPLC separation
profiles are presented for retinoids extracted from the dark-adapted
eyes of 11-
cis-RoDH
+/+ and
11-
cis-RoDH
+/
(Fig.
6A) and
11-
cis-RoDH
/
(Fig.
6B) mice. Because
of 11-
cis-RoDH enzymatic properties in
vitro, increased
11-
cis-retinol concentrations in
11-
cis-RoDH
/
mice were expected. Eyes
derived from 11-
cis-RoDH
/
mice contained
49 ± 22 pmol of 11-
cis-retinol plus
13-
cis-retinol
per eye (mean ± standard error of the
mean [SEM],
n = 3), compared
to 7 ± 0.9 pmol
(mean ± SEM,
n = 3) in
11-
cis-RoDH
+/+ mice (Fig.
6A versus B; see also
Table
1). Small amounts of
these retinols
and large differences in their absorption coefficients
did not allow
precise estimation of the
11-
cis-retinol:13-
cis-retinol
ratio. Rough
estimation based on the spectrum suggests an equal
molar ratio of these
isomers. Although not visible in the chromatogram,
a large increase in
the retinyl ester concentration in the eyes
of
11-
cis-RoDH
/
mice was observed in both dark-
and light-adapted eyes (Tables
1 and
2). To determine the isomeric
composition, retinyl esters
were collected and saponified.
Typical results are shown in Fig.
6A' for
11-
cis-RoDH
+/+ and Fig.
6B' for
11-
cis-RoDH
/
mice. There was a large
increase in the ratio of
cis-retinyl
esters to
all-
trans-retinyl esters in the eyes derived from
dark-adapted
11-
cis-RoDH
/
mice (Fig.
6A'
versus B').

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 6.
11-cis-RoDH mouse ocular retinoid analysis.
(A) Typical chromatogram of retinoid separation for
11-cis-RoDH+/+ and
11-cis-RoDH+/ mice. Note that both
chromatograms are very similar and were superimposed. Peaks: 1, retinyl
esters; 2 and 6, anti- and
syn-11-cis-retinal oximes; 3 and 7, anti- and syn-all-trans-retinal
oximes; 5, all-trans-retinol; 4, 11-cis-retinol
plus 13-cis-retinol. (B) Typical chromatogram of retinoid
separation for 11-cis-RoDH / mice. (A' and
B') Analysis of isomeric composition of retinyl esters obtained for
11-cis-RoDH+/+ and
11-cis-RoDH / mice, respectively. Insets:
UV/VIS spectra of peaks 5 and 4, respectively.
|
|
UV/VIS spectroscopy and coelution with authentic retinoid standards
were used to identify the retinoids. For example, retinoids
present in
peak 5 had a
max at 325 nm (inset in Fig.
6A'), and
their retention time corresponded perfectly to that of the
all-
trans-retinol
standard. Looking at the spectra of peaks
4, we noticed some heterogeneity
(inset, Fig.
6B'), resulting in a
max of between 319 and 330
nm, which suggests a mixture
of 11-
cis-retinol and 13-
cis-retinol
isomers.
13-
cis-Retinol is spontaneously formed at room temperature,
and thus it was necessary to estimate the extent of this reaction
using
synthetic standards. Separation of 11-
cis- and
13-
cis-retinol
was achieved in 1.5% dioxane in hexane. In
addition to a ~4-fold
increase observed in the ester
concentration in 11-
cis-RoDH
/
mice
(Tables
1 and
2), we also observed a
change in the isomeric
composition of the ester pool (Tables
3 and
4).
Analysis shows
a ~50-fold increase in
cis-retinyl ester
concentrations in the
eyes of dark-adapted
11-
cis-RoDH
/
mice. In dark-adapted
11-
cis-RoDH
/
eyes, 73.2% ± 2.4%
(mean ± SEM,
n = 3) is present as
11-
cis-retinyl
esters and 13-
cis-retinyl
esters, compared to only 6.8% ± 3.4%
(mean ± SEM,
n = 3) in dark-adapted 11-
cis-RoDH
+/+ eyes.
Approximately 25% of the total esters are present as the
11-
cis isomer (Table
3). A smaller but significant increase
in
the
cis-retinyl ester concentration in dark-adapted eyes
of 11-
cis-RoDH
+/
mice was also noticed. Other
retinoids were similar to those
in
11-
cis-RoDH
+/+ mice. The concentration of
11-
cis-retinal in all three genotypes
is comparable to the
concentration of rhodopsin, as described
above, suggesting that this
retinal is coupled almost exclusively
with opsin. The retinyl ester
composition in eyes of 11-
cis-RoDH
+/+ mice did
not change significantly following light adaptation
bleaching ~60%
of the rhodopsin present. In 11-
cis-RoDH
+/
and
11-
cis-RoDH
/
eyes, 11-
cis-retinyl
esters were depleted to <2% and ~10%, respectively,
as a result of
light adaptation. Light also caused depletion of
free
cis-retinols in 11-
cis-RoDH
/
eyes.
ERG recordings.
When mice were 3 months old, ERGs of
11-cis-RoDH+/+,
11-cis-RoDH+/
, and
11-cisRoDH
/
mice were recorded at increasing
stimulus intensities under dark-adapted conditions. As a typical
example, we show the original scotopic ERG recordings of an
11-cis-RoDH+/+ mouse and
11-cis-RoDH
/
mouse in Fig.
7A and B, respectively. A difference
between 11-cis-RoDH+/+ mice and
11-cis-RoDH+/
was not observed, and the
results for 11-cis-RoDH+/
mice are therefore
not shown. There is no statistical difference between the scotopic ERG
b-wave amplitudes of 11-cis-RoDH
/
and
11-cis-RoDH+/+ animals after 2 h of dark
adaptation at all intensities tested. The amplitudes for the
11-cis-RoDH
/
mice tend to be even higher.
Interestingly, we also noticed higher concentrations of
11-cis-retinal in 11-cis-RoDH
/
eyes of fully dark-adapted animals (Table 1). The ERG response under
dark-adapted conditions is mainly derived from rod activity, and hence,
rod photoreceptor cells in 11-cis-RoDH
/
mice seem to be fully functional. At 7 months of age, there
was still no difference between the ERG recordings of
11-cis-RoDH
/
and
11-cis-RoDH+/+ animals (data not shown).

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 7.
ERG analysis. Scotopic ERG recordings (A and B) and
photopic ERG recordings (C and D) of a 3-month-old
11-cis-RoDH+/+ mouse (A and C) and a 3-month-old
11-cis-RoDH / mouse (B and D). The onset of
the flash is indicated by open triangles. For scotopic ERGs the flash
intensities used were 0.04 (A), 0.1 (B), 0.4 (C), 1.0 (D), 4.0 (E),
10.0 (F), 100.0 (G), and 1,000 (H) mcd m 2. For photopic
ERGs, mice were exposed to a background light of 30 cd m 2
for 10 min. A single flash response was obtained with 15 cd
m 2.
|
|
The photopic ERGs were recorded after the scotopic ERG recordings and a
light adaptation period (30 cd m
2) of 10 min. It was
assumed that mainly cones contribute to the
ERG response when a
background light of 30 cd m
2 and a flash intensity of 15 cd m
2 is used. As an example, Fig.
7C and D show the
photopic ERG recordings
of an 11-
cis-RoDH
+/+
mouse and an 11-
cis-RoDH
/
mouse,
respectively, at the age of 3 months. Using the
t
test,
there is no statistical difference between the cone
single-response
amplitudes of 11-
cis-RoDH
/
and 11-
cis-RoDH
+/+ mice (
P = 0.44). Hence, in addition to the rod photoreceptor
cells, the cone
photoreceptor cells are also fully functional
in
11-
cis-RoDH
/
mice.
Yamamoto and coworkers reported on mutations in the
11-
cis-RoDH gene of patients suffering from fundus
albipunctatus (
46).
Fundus albipunctatus patients have
normal scotopic and photopic
ERG responses but suffer from abnormal
dark adaptation kinetics.
They often reach normal ERG amplitudes only
after a prolonged
period of dark adaptation. To look for this effect,
five 11-
cis-RoDH
/
mice and five control mice
were dark adapted for 2 h and bleached
with 100 cd
m
2 for 2 min. After the light was turned off, the ERG was
recorded
every minute for 20 min with a flash intensity of 100 mcd
m
2. Under these conditions, the onset time and amplitude
of the
b-waves were not statistically different between
11-
cis-RoDH
/
and
11-
cis-RoDH
+/+ mice, both reaching a maximal
amplitude after ~18 min. A typical
example is shown in Fig.
8A
(11-
cis-RoDH
+/+) and B
(11-
cis-RoDH
/
). The experiment was
modified by using a longer period of dark
adaptation and a higher
bleaching level. After 16 h of dark adaptation,
a prebleach
scotopic ERG was recorded (Fig.
8C, D, and E) and
the anesthetized
animals were subsequently light adapted for 10
min with an 800-cd
m
2 background. Over a 45-min period, a single ERG
response was recorded
every 3 min using a white flash of 100 mcd
m
2 (Fig.
8F, G, and H show typical examples). In control
animals,
a reproducible response emerged after a mean time period of
18
± 3 min (mean ± standard deviation [SD],
n = 9) compared to >45
min (
n = 8) in
11-
cis-RoDH
/
animals. Using the
t test, the difference in dark adaptation
kinetics observed
between 11-
cis-RoDH
/
and
11-
cis-RoDH
+/+ mice was found to be highly
significant (
P > 0.0001). Data show
delayed dark
adaptation in 11-
cis-RoDH
/
mice, provided a
considerable amount of rhodopsin is bleached.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 8.
Dark adaptation. Mice were dark adapted for 2 h and
bleached for 2 min using 100 cd m 2 (A and B). Scotopic
ERGs were recorded every minute during a 20-min period using a flash
intensity of 10 1 cd m 2. B-wave amplitudes
of 11-cis-RoDH / animals (B) compared to
11-cis-RoDH+/+ animals (A) were not delayed. To
achieve a higher level of bleaching, animals were dark adapted for
16 h and bleached for 10 min using 800 cd m 2. A
prebleaching ERG using a flash of 10 1 cd m 2
was recorded (C, D, and E). After the bleach an ERG was recorded again
using a flash of 10 1 cd m 2 every 3 min (F,
G, and H). In all 11-cis-RoDH+/+ mice, an ERG
was recorded after ~18 min (F, typical example) similar to the
prebleach ERG. After 18 min, no ERG could be detected in any of the
11-cis-RoDH / mice (G and H). Two
11-cis-RoDH / mice started to respond after
42 min (G), but most 11-cis-RoDH / mice did
not respond after 45 min (H), by which time we had to terminate the
experiment for reasons mentioned in the text.
|
|
 |
DISCUSSION |
General consequences because of 11-cis-RoDH function
loss.
This report describes the construction of an
11-cis-RoDH knockout animal model. The
11-cis-RoDH enzyme was found to be capable of catalyzing the
oxidation of cis-isomers of retinol, including 11-cis-, 9-cis-, and 13-cis-retinol
(4, 6, 22, 37, 42). Oxidation of 9-cis-retinol to
9-cis-retinaldehyde is likely to be the first step in the
9-cis-retinoic acid (RA) biosynthesis pathway. RA plays an
important role in differentiation, apoptosis, and reproduction by
regulating gene transcription through interaction with retinoid
receptors, several of which are present in the (pre)mature vertebrate
retina (3, 11, 27, 43). Romert and coworkers found that the
murine 11-cis-RoDH gene is transcribed in embryonic tissues
as early as gestation day 9 (32), which, taken together with
its substrate specificity, hints at involvement of
11-cis-RoDH in prenatal development through
9-cis-RA biosynthesis. However, 11-cis-RoDH
turned out not to be essential for embryonic development and viability.
This shows that 11-cis-RoDH is possibly not involved in
9-cis-RA biosynthesis prenatally or 9-cis-RA is
not essential for embryonic development or
11-cis-RoDH
/
mice can compensate for the
loss of 11-cis-RoDH activity. Wang and coworkers showed that
the enzyme could be involved in 5
-androstan-3
, 17
-diol, and
andosterone metabolism and therefore might influence fertility
(42). However, both female and male
11-cis-RoDH
/
mice were found to be fertile,
and moreover, 11-cis-RoDH
/
couples gave
birth to ~50% female and 50% male offspring. In conclusion, the
data thus far did not present us with evidence for a crucial role of
11-cis-RoDH in the 9-cis-RA biosynthetic pathway
or steroid metabolism in vivo.
Visual cycle in 11-cis-RoDH
/
mice.
A striking phenotypic characteristic of
11-cis-RoDH
/
mice is overproduction of
11-cis-retinol, accumulating as a free alcohol and in the
form of retinyl esters. Lack of 11-cis-RoDH did not affect
production of 11-cis-retinal, suggesting that another
oxidizing system is taking over for the production of this important
aldehyde. Indeed, using a combination of NAD and NADP, we recently
postulated the presence of an additional NADP-dependent oxidizing
system in RPE (35). In mice, the absence of
11-cis-RoDH could be compensated for by a higher
concentration of its substrate, 11-cis-retinol. A higher
11-cis-retinol concentration might be necessary if, for example, a second oxidation system is less efficient (high
Km) in production of 11-cis-retinal.
High-level production of 11-cis-retinol upon disruption of
the visual cycle complex might be the result of deinhibition of an
enzyme(s) involved in the isomerization of all-trans-retinol
to 11-cis-retinol.
The isomerization of all-
trans-retinol to
11-
cis-retinol occurs enzymatically without an exogenous
source of energy (
1).
Hydrolysis of
all-
trans-retinyl carboxylic ester provides the
4 kcal/mol
energy needed for isomerization, and retinyl esters
were proposed to be
essential intermediates in 11-
cis-retinol
formation. More
recently, Winston and Rando (
45) proposed that
11-
cis-retinol (and to a lesser degree
13-
cis-retinol) is a very
potent inhibitor of isomerization.
This observation would explain
why
11-
cis-RoDH
+/+ mice do not complete conversion
of all-
trans-retinyl esters to
11-
cis-retinyl
esters (see, for example, Fig.
6) in this putative
exothermic reaction.
However, as shown in Fig.
6, 11-
cis-RoDH
/
mice overproduce 11-
cis-retinol and
11-
cis-retinyl esters, suggesting
that isomerization could
occur in vivo even in the presence of
high 11-
cis-retinol or
11-
cis-retinyl ester levels. Hence, overproduction
of
11-
cis-retinol in 11-
cis-RoDH
/
mice did not inhibit conversion of all-
trans-retinyl esters
but
was, on the contrary, found to increase formation of
11-
cis-retinoids.
This isomerization model has been challenged recently (
40).
It was proposed that apo-CRALBP or another binding system of
11-
cis-retinol appears to be necessary in vitro to monitor
isomerase
activity. A similar mechanism might operate in vivo. The
retinoid-binding
proteins that drive the reaction may overcome the
thermodynamically
unfavorable isomerization reaction. In this model,
all-
trans-retinol
or an unidentified retinyl intermediate
participates in the isomerization
reaction. Formed
11-
cis-retinol is oxidized to 11-
cis-retinal
and
saturates the binding sites (driving force for isomerization).
The
consequence of isomerization proceeding only in the presence
of the
acceptor protein(s) would be that an 11-
cis-retinal pool
does not accumulate in RPE because it is only formed on demand.
Lack of
sufficient 11-
cis-retinol oxidation capacity could result
in
overproduction of unbound 11-
cis-retinol because it binds to
CRALBP with lower affinity than 11-
cis-retinal
(
33). The system
would try to establish a new equilibrium,
and higher levels of
11-
cis-retinyl esters could be a way of
reaching this equilibrium.
The 11-
cis-RoDH
/
mice behave as predicted by this model. Hence, the availability
of mice
with disrupted 11-
cis-RoDH activity will be very useful
to
obtain additional insights into the isomerization
reaction.
An unexpected observation was the high level of
13-
cis-retinyl esters in
11-
cis-RoDH
/
mice. 11-
cis-RoDH is
a promiscuous enzyme toward
cis-isomers
of retinols (
6,
22,
35,
42). Purified enzyme reduces
both 11-
cis- and
13-
cis-retinal with similar efficiency
(
Km, 4.6
and 4.4 µM; respectively;
Vmax, 568 and 440 nmol/min per mg with
NADH,
respectively; G.-F. Jang, K. Palczewski, and F. Haeseleer,
unpublished). In fact, the dehydrogenase is somewhat more efficient
towards 11-
cis- and 13-
cis-retinal than
9-
cis-retinal (2.2 µM
and 130 nmol/min per mg). Because
13-
cis-retinol is formed spontaneously
at ambient
temperature and has no known physiological function,
it is likely that
a mechanism which strives to remove this analog
from circulation is
present. This may be even more the case in
a tissue like the retina,
which experiences high fluxes of retinoids.
The lack of
11-
cis-RoDH in RoDH
/
mice for the first time
reveals in vivo accumulation of 13-
cis-retinol,
for the
major part in the form of esters. These observations raise
many
questions regarding the metabolism of 13-
cis-retinol. The
generated knockout animals are useful for elucidating further
details
of this
process.
11-cis-RoDH-deficient mice as a model of fundus
albipunctatus.
Under normal environmental conditions,
11-cis-RoDH knockout mice did not display white punctata
resembling those observed in the fundus of fundus albipunctatus
patients. Punctata are present from the day of birth and show no or
little progression during a patient's lifetime. It is likely that the
flecked retina typical of fundus albipunctatus patients results from a
developmental defect. This is likely to be caused by a role of
11-cis-RoDH in RA biosynthesis. RA was shown to be an
important regulator of the rod photoreceptor development (12,
13). Fundus differences observed between humans and mice might be
the result of differences in RA action. It was shown that in
higher primates, Müller cells contain cellular
RA-binding protein (CRABP), whereas the Müller cells of rats and
rabbits do not (23). Müller cells produce neurotrophins that are important for rod photoreceptor development (14, 15, 26). RA could control the expression of
neurotrophins in Müller cells of primates and not in rodents.
Indeed, RA was reported to regulate expression of the ciliary
neurotrophic factor (25). Hence, photoreceptor
differentiation regulated through Müller cells could be different
in humans and mice.
From our analysis, it is clear that at high bleaching levels,
11-
cis-RoDH
/
mice have delayed dark adaption
kinetics, as do humans suffering
from mutations in the gene encoding
11-
cis-RoDH (
46). However,
in fully
dark-adapted 11-
cis-RoDH
/
mice, a rod
ERG response comparable to that of
11-
cis-RoDH
+/+ mice was measured. Hence,
11-
cis-RoDH
/
mice are still capable of
regenerating their rod visual pigment,
which means that, in addition to
11-
cis-RoDH, another unknown
enzyme(s) is able to catalyze
11-
cis-retinol oxidation in the
retina. Recently,
11-
cis-RoDH activity was also found to be associated
with
plasma membrane (PM) fractions (
19). 11-
cis-RoDH,
however,
was found to be associated with the endoplasmic reticulum (ER)
of RPE cells (
39). A second enzyme capable of
11-
cis-retinol
oxidation is therefore likely to be present
in the PM of RPE cells.
11-
cis-Retinyl ester hydrolase
activity was also found to be present
within the PM (
20).
11-
cis-Retinal biosynthesis could therefore
occur both in
the ER and at the PM. Loss of 11-
cis-retinol oxidation
capacity in the ER of 11-
cis-RoDH
/
mice
resulted in a 50-fold increase in the
cis-retinyl ester
concentration. The 11-
cis-retinyl ester and
11-
cis-retinyl ester
hydrolase were shown to colocalize in
the RPE PM (
18). A high
11-
cis-retinyl ester
concentration in the PM of 11-
cis-RoDH
/
mice
could prove to be a better subcellular locale for production
of
11-
cis-retinal in mice than in humans. Hence, in different
species the relative contribution to 11-
cis-retinal
biosynthesis
by each of the two subcellular compartments could be
different.
This is also emphasized by the observation that at bleaching
levels
at which patients suffering from fundus albipunctatus can be
diagnosed
unequivocally, 11-
cis-RoDH
/
mice
still show normal dark adaptation
kinetics.
Recent studies in humans show that lack of retinol-binding protein in
serum progressively affects both retinal morphology
and function
(
36). However, young mice lacking serum retinol-binding
protein (SRBP) have abnormal ERGs that become normal by 5 months
of age
(
30). It was suggested that in mice, SRBP functions to
store
vitamin A and is necessary to release retinol from hepatic
retinol
stores. A phenotype with regard to retinal function therefore
only
became overt when the SRBP knockout animals were placed on
a vitamin
A-deficient diet. Hence, unlike humans, mice with retinol-binding
protein deficiency develop a normal functioning retina, although
at a
slower pace than their wild-type littermates. Also, the structure
of the retina in SRBP-deficient mice is reported to be normal,
whereas
humans develop atrophic RPE and focal loss of RPE in addition
to
macular pathology. Hence, SRBP-deficient mice do not phenotypically
mimic the disease phenotype observed in humans. Both the
11-
cis-RoDH
and SRBP knockout mouse models suggest that mice
are better able
to adapt or make use of different metabolic routes for
retinoid
metabolism than humans, resulting in less pronounced retinal
pathology.
 |
ACKNOWLEDGMENTS |
We thank W. van den Broek and F. Oerlemans for helpful discussions.
We acknowledge the technical support of the Central Animal Laboratory
of the University of Nijmegen. This work was supported by grants from
the following foundations: Rotterdamse Vereniging Blindenbelangen, Stichting Blindenhulp, and Deutsche
Forschungsgemeinschaft (Ru 457/6-3). This research was
further supported by NIH grant EY09339 (K.P.), an award from Research
to Prevent Blindness, Inc. (R.P.B.), to the Department of Ophthalmology
at the University of Washington, and the E. K. Bishop Foundation.
K.P. is a Bishop Professor.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Ophthalmology, University of Nijmegen, Philips van Leijdenlaan
15, 6525 EX Nijmegen, The Netherlands. Phone: 31243615160. Fax: 31243540522. E-mail:
c.driessen{at}ohk.azn.nl.
 |
REFERENCES |
| 1.
|
Bernstein, P. S.,
W. C. Law, and R. R. Rando.
1987.
Isomerization of all-trans-retinoids to 11-cis-retinoids.
Proc. Natl. Acad. Sci. USA
84:1849-1853[Abstract/Free Full Text].
|
| 2.
|
Chai, X.,
Y. Zhai, and J. L. Napoli.
1997.
cDNA cloning and characterization of a cis-retinol/3 -hydroxysterol short-chain alcohol dehydrogenase.
J. Biol. Chem.
272:33125-33131[Abstract/Free Full Text].
|
| 3.
|
Dolle, P.,
V. Fraulob,
P. Kastner, and P. Chambon.
1994.
Developmental expression of murine retinoid X receptor (RXR) genes.
Mech. Dev.
45:91-104[CrossRef][Medline].
|
| 4.
|
Driessen, C. A. G. G.,
A. P. M. Janssen,
H. J. Winkens,
A. H. M. Van Vugt,
A. L. M. De Leeuw, and J. J. M. Janssen.
1995.
Cloning and expression of a cDNA encoding bovine retinal pigment epithelial 11-cis-retinol dehydrogenase.
Invest. Ophthalmol. Vis. Sci.
36:1988-1996[Abstract/Free Full Text].
|
| 5.
|
Driessen, C. A. G. G.,
H. J. Winkens,
E. D. Kuhlmann,
A. P. M. Janssen,
A. H. M. Van Vugt,
A. F. Deutman, and J. J. M. Janssen.
1997.
Cloning and structural analysis of the murine GCN5L1 gene.
Gene
208:27-31[CrossRef].
|
| 6.
|
Driessen, C. A. G. G.,
H. J. Winkens,
E. D. Kuhlmann,
A. P. M. Janssen,
A. H. M. Van Vugt,
A. F. Deutman, and J. J. M. Janssen.
1998.
The visual cycle retinol dehydrogenase: possible involvement in the 9-cis-retinoic acid pathway.
FEBS Lett.
428:135-140[CrossRef][Medline].
|
| 7.
|
Goto, Y.,
N. S. Peachey,
H. Ripps, and M. I. Naash.
1995.
Functional abnormalities in transgenic mice expressing a mutant rhodopsin gene.
Invest. Ophthalmol. Vis. Sci.
36:62-71[Abstract/Free Full Text].
|
| 8.
|
Gu, S.,
D. A. Thompson,
S. Srikumari,
B. Lorenz,
U. Finckh,
A. Nicoletti,
K. R. Murthy,
M. Rathmann,
G. Kumaramanickavel,
M. J. Denton, and A. Gal.
1997.
Mutations in RPE65 cause autosomal recessive childhood-onset severe retinal dystropy.
Nat. Genet.
17:194-197[CrossRef][Medline].
|
| 9.
|
Humphries, M. M.,
D. Rancourt,
G. J. Farrar,
P. Kenna,
M. Hazel,
R. A. Bush,
P. A. Sieving,
D. M. Sheils,
N. McNally,
P. Creighton,
A. Erven,
A. Boros,
K. Gulya,
M. R. Capecchi, and P. Humphries.
1997.
Retinopathy induced in mice by targeted disruption of the rhodopsin gene.
Nat. Genet.
15:216-219[CrossRef][Medline].
|
| 10.
|
Janssen, J. J. M.,
A. P. M. Janssen, and A. H. M. Van Vugt.
1994.
Characterization of monoclonal antibodies recognizing retinal pigment epithelial antigens.
Invest. Ophthalmol. Vis. Sci.
35:189-198[Abstract/Free Full Text].
|
| 11.
|
Janssen, J. J. M.,
E. D. Kuhlmann,
A. H. M. Van Vugt,
H. J. Winkens,
A. P. M. Janssen,
A. F. Deutman, and C. A. G. G. Driessen.
1999.
Retinoic acid receptors and retinoid X receptors in the mature retina: subtype determination and cellular distribution.
Curr. Eye Res.
19:338-347[CrossRef][Medline].
|
| 12.
|
Kelley, M. W.,
J. K. Turner, and T. A. Reh.
1994.
Retinoic acid promotes differentiation of photoreceptors in vitro.
Development
120:2091-2102[Abstract].
|
| 13.
|
Kelley, M. W.,
R. C. Williams,
J. K. Turner,
J. M. Creech-Kraft, and T. A. Reh.
1999.
Retinoic acid promotes rod photoreceptor differentiation in rat retina in vivo.
Neuroreport
10:2389-2394[Medline].
|
| 14.
|
Kirsch, M.,
M. Y. Lee,
V. Meyer,
A. Wiese, and H. D. Hofmann.
1997.
Evidence for multiple, local functions of ciliary neurotrophic factor (CNTF) in retinal development: expression of CNTF and its receptors and in vitro effects on target cells.
J. Neurochem.
68:979-990[Medline].
|
| 15.
|
Kirsch, M.,
S. Schulz-Key,
A. Wiese,
S. Fuhrmann, and H. Hofmann.
1998.
Ciliary neurotrophic factor blocks rod photoreceptor differentiation from postmitotic precursor cells in vitro.
Cell Tissue Res.
291:207-216[CrossRef][Medline].
|
| 16.
|
Lem, J.,
N. V. Krasnoperova,
P. D. Calvert,
B. Kosaras,
D. A. Cameron,
M. Nicolo,
C. L. Makino, and R. L. Sidman.
1999.
Morphological, physiological, and biochemical changes in rhodopsin knock-out mice.
Proc. Natl. Acad. Sci. USA
96:736-741[Abstract/Free Full Text].
|
| 17.
|
Liou, G. I.,
Y. Fei,
N. S. Peachey,
S. Matragoon,
S. Wei,
W. S. Blaner,
Y. Wang,
C. Liu,
M. E. Gottesman, and H. Ripps.
1998.
Early onset photoreceptor abnormalities induced by targeted disruption of the interphotoreceptor retinoid-binding protein gene.
J. Neurosci.
18:4511-4520[Abstract/Free Full Text].
|
| 18.
|
Marlhens, F.,
C. Bareil,
J. Griffoin,
E. Zrenner,
P. Amalric,
C. Eliaou,
S. Liu,
E. Harris,
T. M. Redmond,
B. Arnaud,
M. Claustress, and C. P. Hamel.
1997.
Mutations in RPE65 cause Leber's congenital amaurosis.
Nat. Genet.
17:139-141[CrossRef][Medline].
|
| 19.
|
Mata, N. L., and A. T. Tsin.
1998.
Distribution of 11-cis LRAT, 11-cis RD and 11-cis REH in bovine retinal pigment epithelium membranes.
Biochim. Biophys. Acta
1394:16-22[Medline].
|
| 20.
|
Mata, N. L.,
E. T. Villazana, and A. T. Tsin.
1998.
Colocalization of 11-cis retinyl esters and retinyl ester hydrolase activity in retinal pigment epithelium plasma membrane.
Invest. Ophthalmol. Vis. Sci.
39:1312-1319[Abstract/Free Full Text].
|
| 21.
|
Maw, M. A.,
B. Kennedy,
A. Knight,
R. Bridges,
K. E. Roth,
E. J. Mani,
J. K. Mukkadan,
D. Nancarrow,
J. W. Crabb, and M. J. Denton.
1997.
Mutation of the gene encoding cellular retinaldehyde binding protein in autosomal recessive retinitis pigmentosa.
Nat. Genet.
17:198-200[CrossRef][Medline].
|
| 22.
|
Mertz, J. R.,
E. Shang,
R. Piantedosi,
S. Wei,
D. J. Wolgemuth, and W. S. Blaner.
1997.
Identification and characterization of a stereospecific human enzyme that catalyzes 9-cis-retinol oxidation: a possible role in 9-cis-retinoic acid formation.
J. Biol. Chem.
272:11744-11749[Abstract/Free Full Text].
|
| 23.
|
Milam, A. H.,
A. M. De Leeuw,
V. P. Gaur, and J. C. Saari.
1990.
Immunolocalization of cellular retinoic acid binding protein to Müller cells and/or a subpopulation of GABA-positive amacrine cells in retinas of different species.
J. Comp. Neurol.
296:123-129[CrossRef][Medline].
|
| 24.
|
Morimura, H.,
G. A. Fishmann,
S. A. Grover,
A. B. Fulton,
E. L. Berson, and T. P. Dryja.
1998.
Mutations in the RPE65 gene in patients with autosomal recessive retinitis pigmentosa or Leber congenital amaurosis.
Proc. Natl. Acad. Sci. USA
95:3088-3093[Abstract/Free Full Text].
|
| 25.
|
Nakanishi, T.,
K. Ishii,
N. Fukushima,
M. Asanuma,
E. Iwata, and N. Ogawa.
1996.
Expression of mRNA encoding neurotrophic factors and its regulation in a hybrid neuronal cell line.
Biochem. Mol. Biol. Int.
38:763-772[Medline].
|
| 26.
|
Neophytou, C.,
A. B. Vernallis,
A. Smith, and M. C. Raff.
1997.
Müller-cell-derived leukaemia inhibitory factor arrests rod photoreceptor differentiation at a postmitotic pre-rod stage of development.
Development
124:2345-2354[Abstract].
|
| 27.
|
Niederreither, K.,
V. Subbarayan,
P. Dolle, and P. Chambon.
1999.
Embryonic retinoic acid synthesis is essential for early mouse post-implantation development.
Nat. Genet.
21:444-448[CrossRef][Medline].
|
| 28.
|
Palczewski, K., and J. C. Saari.
1997.
Activation and inactivation steps in the visual transduction pathway.
Curr. Opin. Neurobiol.
7:500-504[CrossRef][Medline].
|
| 29.
|
Palczewski, K.,
J. P. VanHooser,
G. G. Garwin,
J. Chen,
G. I. Liou, and J. C. Saari.
1999.
Kinetics of visual pigment regeneration in excised mouse eyes and in mice with a targeted disruption of the gene encoding interphotoreceptor retinoid-binding protein or arrestin.
Biochemistry
38:12012-12019[CrossRef][Medline].
|
| 30.
|
Quadro, L.,
W. S. Blaner,
D. Salchow,
S. Vogel,
R. Piantedosi,
P. Gouras,
S. Freeman,
M. P. Cosma,
V. Colantuoni, and M. E. Gottesman.
1999.
Impaired retinal function and vitamin A availability in mice lacking retinol-binding protein.
EMBO J.
18:4633-4644[CrossRef][Medline].
|
| 31.
|
Redmond, T. M.,
S. Yu,
E. Lee,
D. Bok,
D. Hamasaki,
N. Chen,
P. Goletz,
J. X. Ma,
R. K. Crouch, and K. Pfeifer.
1998.
RPE65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle.
Nat. Genet.
20:344-351[CrossRef][Medline].
|
| 32.
|
Romert, A.,
P. Tuvendal,
A. Simon,
L. Dencker, and U. Eriksson.
1998.
The identification of a 9-cis-retinol dehydrogenase in the mouse embryo reveals a pathway for synthesis of 9-cis-retinoic acid.
Proc. Natl. Acad. Sci. USA
95:4404-4409[Abstract/Free Full Text].
|
| 33.
|
Saari, J. C., and D. L. Bredberg.
1987.
Photochemistry and stereoselectivity of cellular retinaldehyde-binding protein from bovine retina.
J. Biol. Chem.
262:7618-7622[Abstract/Free Full Text].
|
| 34.
|
Saari, J. C.,
G. G. Garwin,
J. P. Van Hooser, and K. Palczewski.
1998.
Reduction of all-trans-retinal limits regeneration of visual pigment in mice.
Vision Res.
38:1325-1333[CrossRef][Medline].
|
| 35.
|
Saari, J. C.,
G. G. Garwin,
F. Haeseleer,
G.-F. Jang, and K. Palczewski.
2000.
Phase partition and high-performance liquid chromatography assays of retinoid dehydrogenases.
Methods Enzymol.
316:359-371[Medline].
|
| 36.
|
Seeliger, M. W.,
I. Frank,
S. Beck, and E. Zrenner.
1999.
Phenotype in retinol deficiency due to a hereditary defect in retinol binding protein biosynthesis.
Invest. Ophthalmol. Vis. Sci.
40:3-11[Abstract/Free Full Text].
|
| 37.
|
Simon, A.,
U. Hellman,
C. Wernstedt, and U. Eriksson.
1995.
The retinal pigment epithelial-specific 11-cis-retinol dehydrogenase belongs to the family of short chain alcohol dehydrogenase.
J. Biol. Chem.
270:1107-1112[Abstract/Free Full Text].
|
| 38.
|
Simon, A.,
J. Lagercrantz,
S. Bajalica-Lagercrantz, and U. Eriksson.
1996.
Primary structure of human 11-cis-retinol dehydrogenase and organization and chromosomal localization of the corresponding gene.
Genomics
36:424-430[CrossRef][Medline].
|
| 39.
|
Simon, A.,
A. Romert,
A. L. Gustafson,
J. M. McCaffery, and U. Eriksson.
1999.
Intracellular localization and membrane topology of 11-cis retinol dehydrogenase in the retinal pigment epithelium suggest a compartmentalized synthesis of 11-cis retinaldehyde.
J. Cell Sci.
112:549-558[Abstract].
|
| 40.
|
Stecher, H.,
M. H. Gelb,
J. C. Saari, and K. Palczewski.
1999.
Preferential release of 11-cis-retinol from retinal pigment epithelial cells in the presence of cellular retinaldehyde-binding protein.
J. Biol. Chem.
274:8577-8585[Abstract/Free Full Text].
|
| 41.
|
Su, J.,
X. Chai,
B. Kahn, and J. L. Napoli.
1998.
cDNA cloning, tissue distribution, and substrate characteristics of a cis-retinol/3 -hydroxysterol short-chain dehydrogenase isozyme.
J. Biol. Chem.
273:17910-17916[Abstract/Free Full Text].
|
| 42.
|
Wang, J.,
X. Chai,
U. Eriksson, and J. L. Napoli.
1999.
Activity of human 11-cis-retinol dehydrogenase (Rdh5) with steroids and retinoids and expression of its mRNA in extra-ocular human tissue.
Biochem. J.
338:23-27.
|
| 43.
|
Wendling, O.,
P. Chambon, and M. Mark.
1999.
Retinoid X receptors are essential for early mouse development and placentogenesis.
Proc. Natl. Acad. Sci. USA
96:547-551[Abstract/Free Full Text].
|
| 44.
|
Weng, J.,
N. L. Mata,
S. M. Azarian,
R. T. Tzekov,
D. G. Birch, and G. H. Travis.
1999.
Insights into the function of rim protein in photoreceptors and etiology of Stargardt's disease from the phenotype in abcr knockout mice.
Cell
98:13-23[CrossRef][Medline].
|
| 45.
|
Winston, A., and R. R. Rando.
1998.
Regulation of isomerohydrolase activity in the visual cycle.
Biochemistry
37:2044-2050[CrossRef][Medline].
|
| 46.
|
Yamamoto, H.,
A. Simon,
U. Eriksson,
E. Harris,
E. L. Berson, and T. P. Dryja.
1999.
Mutations in the gene encoding 11-cis-retinol dehydrogenase cause delayed dark adaptation and fundus albipunctatus.
Nat. Genet.
22:188-191[CrossRef][Medline].
|
| 47.
|
Yang, R. B.,
S. W. Robinson,
W. H. Xiong,
K. W. Yau,
D. G. Birch, and D. L. Garbers.
1999.
Disruption of a retinal guanylyl cyclase gene leads to cone-specific dystrophy and paradoxical rod behavior.
J. Neurosci.
19:5889-5897[Abstract/Free Full Text].
|
| 48.
|
Zimmerman, W. F.,
F. Lion,
F. J. M. Daemen, and S. L. Bonting.
1975.
Biochemical aspects of the visual process. XXX. Distribution of stereospecific dehydrogenase activities in subcellular fractions of the bovine retina and pigment epithelium.
Exp. Eye Res.
21:325-332[CrossRef][Medline].
|
Molecular and Cellular Biology, June 2000, p. 4275-4287, Vol. 20, No. 12
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Farjo, K. M., Moiseyev, G., Takahashi, Y., Crouch, R. K., Ma, J.-x.
(2009). The 11-cis-Retinol Dehydrogenase Activity of RDH10 and Its Interaction with Visual Cycle Proteins. IOVS
50: 5089-5097
[Abstract]
[Full Text]
-
Kusakabe, T. G., Takimoto, N., Jin, M., Tsuda, M.
(2009). Evolution and the origin of the visual retinoid cycle in vertebrates. Phil Trans R Soc B
364: 2897-2910
[Abstract]
[Full Text]
-
Chrispell, J. D., Feathers, K. L., Kane, M. A., Kim, C. Y., Brooks, M., Khanna, R., Kurth, I., Hubner, C. A., Gal, A., Mears, A. J., Swaroop, A., Napoli, J. L., Sparrow, J. R., Thompson, D. A.
(2009). Rdh12 Activity and Effects on Retinoid Processing in the Murine Retina. J. Biol. Chem.
284: 21468-21477
[Abstract]
[Full Text]
-
Maeda, A., Maeda, T., Sun, W., Zhang, H., Baehr, W., Palczewski, K.
(2007). Redundant and unique roles of retinol dehydrogenases in the mouse retina. Proc. Natl. Acad. Sci. USA
104: 19565-19570
[Abstract]
[Full Text]
-
Kurth, I., Thompson, D. A., Ruther, K., Feathers, K. L., Chrispell, J. D., Schroth, J., McHenry, C. L., Schweizer, M., Skosyrski, S., Gal, A., Hubner, C. A.
(2007). Targeted Disruption of the Murine Retinal Dehydrogenase Gene Rdh12 Does Not Limit Visual Cycle Function. Mol. Cell. Biol.
27: 1370-1379
[Abstract]
[Full Text]
-
Wenzel, A., von Lintig, J., Oberhauser, V., Tanimoto, N., Grimm, C., Seeliger, M. W.
(2007). RPE65 Is Essential for the Function of Cone Photoreceptors in NRL-Deficient Mice. IOVS
48: 534-542
[Abstract]
[Full Text]
-
Jacobson, S. G., Cideciyan, A. V., Aleman, T. S., Sumaroka, A., Schwartz, S. B., Windsor, E. A. M., Roman, A. J., Heon, E., Stone, E. M., Thompson, D. A.
(2007). RDH12 and RPE65, Visual Cycle Genes Causing Leber Congenital Amaurosis, Differ in Disease Expression. IOVS
48: 332-338
[Abstract]
[Full Text]
-
Maeda, A., Maeda, T., Imanishi, Y., Sun, W., Jastrzebska, B., Hatala, D. A., Winkens, H. J., Hofmann, K. P., Janssen, J. J., Baehr, W., Driessen, C. A., Palczewski, K.
(2006). Retinol Dehydrogenase (RDH12) Protects Photoreceptors from Light-induced Degeneration in Mice. J. Biol. Chem.
281: 37697-37704
[Abstract]
[Full Text]
-
Maeda, A., Maeda, T., Palczewski, K.
(2006). Improvement in Rod and Cone Function in Mouse Model of Fundus albipunctatus after Pharmacologic Treatment with 9-cis-Retinal.. IOVS
47: 4540-4546
[Abstract]
[Full Text]
-
Liden, M., Eriksson, U.
(2006). Understanding Retinol Metabolism: Structure and Function of Retinol Dehydrogenases. J. Biol. Chem.
281: 13001-13004
[Full Text]
-
Redmond, T. M., Poliakov, E., Yu, S., Tsai, J.-Y., Lu, Z., Gentleman, S.
(2005). Mutation of key residues of RPE65 abolishes its enzymatic role as isomerohydrolase in the visual cycle. Proc. Natl. Acad. Sci. USA
102: 13658-13663
[Abstract]
[Full Text]
-
Wenzel, A., Oberhauser, V., Pugh, E. N. Jr., Lamb, T. D., Grimm, C., Samardzija, M., Fahl, E., Seeliger, M. W., Reme, C. E., von Lintig, J.
(2005). The Retinal G Protein-coupled Receptor (RGR) Enhances Isomerohydrolase Activity Independent of Light. J. Biol. Chem.
280: 29874-29884
[Abstract]
[Full Text]
-
Strauss, O.
(2005). The Retinal Pigment Epithelium in Visual Function. Physiol. Rev.
85: 845-881
[Abstract]
[Full Text]
-
Maeda, A., Maeda, T., Imanishi, Y., Kuksa, V., Alekseev, A., Bronson, J. D., Zhang, H., Zhu, L., Sun, W., Saperstein, D. A., Rieke, F., Baehr, W., Palczewski, K.
(2005). Role of Photoreceptor-specific Retinol Dehydrogenase in the Retinoid Cycle in Vivo. J. Biol. Chem.
280: 18822-18832
[Abstract]
[Full Text]
-
Niwa, Y., Kondo, M., Ueno, S., Nakamura, M., Terasaki, H., Miyake, Y.
(2005). Cone and Rod Dysfunction in Fundus Albipunctatus with RDH5 Mutation: An Electrophysiological Study. IOVS
46: 1480-1485
[Abstract]
[Full Text]
-
Kim, T. S., Maeda, A., Maeda, T., Heinlein, C., Kedishvili, N., Palczewski, K., Nelson, P. S.
(2005). Delayed Dark Adaptation in 11-cis-Retinol Dehydrogenase-deficient Mice: A ROLE OF RDH11 IN VISUAL PROCESSES IN VIVO. J. Biol. Chem.
280: 8694-8704
[Abstract]
[Full Text]
-
Nadauld, L. D., Sandoval, I. T., Chidester, S., Yost, H. J., Jones, D. A.
(2004). Adenomatous Polyposis Coli Control of Retinoic Acid Biosynthesis Is Critical for Zebrafish Intestinal Development and Differentiation. J. Biol. Chem.
279: 51581-51589
[Abstract]
[Full Text]
-
Gollapalli, D. R., Rando, R. R.
(2004). The specific binding of retinoic acid to RPE65 and approaches to the treatment of macular degeneration. Proc. Natl. Acad. Sci. USA
101: 10030-10035
[Abstract]
[Full Text]
-
Batten, M. L., Imanishi, Y., Maeda, T., Tu, D. C., Moise, A. R., Bronson, D., Possin, D., Van Gelder, R. N., Baehr, W., Palczewski, K.
(2004). Lecithin-retinol Acyltransferase Is Essential for Accumulation of All-trans-Retinyl Esters in the Eye and in the Liver. J. Biol. Chem.
279: 10422-10432
[Abstract]
[Full Text]
-
Molotkov, A., Duester, G.
(2003). Genetic Evidence That Retinaldehyde Dehydrogenase Raldh1 (Aldh1a1) Functions Downstream of Alcohol Dehydrogenase Adh1 in Metabolism of Retinol to Retinoic Acid. J. Biol. Chem.
278: 36085-36090
[Abstract]
[Full Text]
-
Radu, R. A., Mata, N. L., Nusinowitz, S., Liu, X., Sieving, P. A., Travis, G. H.
(2003). From the Cover: Treatment with isotretinoin inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration. Proc. Natl. Acad. Sci. USA
100: 4742-4747
[Abstract]
[Full Text]
-
Qtaishat, N. M., Redmond, T. M., Pepperberg, D. R.
(2003). Acute Radiolabeling of Retinoids in Eye Tissues of Normal and Rpe65-Deficient Mice. IOVS
44: 1435-1446
[Abstract]
[Full Text]
-
Haeseleer, F., Jang, G.-F., Imanishi, Y., Driessen, C. A. G. G., Matsumura, M., Nelson, P. S., Palczewski, K.
(2002). Dual-substrate Specificity Short Chain Retinol Dehydrogenases from the Vertebrate Retina. J. Biol. Chem.
277: 45537-45546
[Abstract]
[Full Text]
-
Molotkov, A., Fan, X., Deltour, L., Foglio, M. H., Martras, S., Farres, J., Pares, X., Duester, G.
(2002). Stimulation of retinoic acid production and growth by ubiquitously expressed alcohol dehydrogenase Adh3. Proc. Natl. Acad. Sci. USA
99: 5337-5342
[Abstract]
[Full Text]
-
Molotkov, A., Deltour, L., Foglio, M. H., Cuenca, A. E., Duester, G.
(2002). Distinct Retinoid Metabolic Functions for Alcohol Dehydrogenase Genes Adh1 and Adh4 in Protection against Vitamin A Toxicity or Deficiency Revealed in Double Null Mutant Mice. J. Biol. Chem.
277: 13804-13811
[Abstract]
[Full Text]
-
Shang, E., Lai, K., Packer, A. I., Paik, J., Blaner, W. S., de Morais Vieira, M., Gouras, P., Wolgemuth, D. J.
(2002). Targeted disruption of the mouse cis-retinol dehydrogenase gene: visual and nonvisual functions. J. Lipid Res.
43: 590-597
[Abstract]
[Full Text]
-
McBee, J. K., Van Hooser, J. P., Jang, G.-F., Palczewski, K.
(2001). Isomerization of 11-cis-Retinoids to All-trans-retinoids in Vitro and in Vivo. J. Biol. Chem.
276: 48483-48493
[Abstract]
[Full Text]
-
Jang, G.-F., McBee, J. K., Alekseev, A. M., Haeseleer, F., Palczewski, K.
(2000). Stereoisomeric Specificity of the Retinoid Cycle in the Vertebrate Retina. J. Biol. Chem.
275: 28128-28138
[Abstract]
[Full Text]
-
Tryggvason, K., Romert, A., Eriksson, U.
(2001). Biosynthesis of 9-cis-Retinoic Acid in Vivo. THE ROLES OF DIFFERENT RETINOL DEHYDROGENASES AND A STRUCTURE-ACTIVITY ANALYSIS OF MICROSOMAL RETINOL DEHYDROGENASES. J. Biol. Chem.
276: 19253-19258
[Abstract]
[Full Text]
-
Jang, G.-F., Van Hooser, J. P., Kuksa, V., McBee, J. K., He, Y.-G., Janssen, J. J. M., Driessen, C. A. G. G., Palczewski, K.
(2001). Characterization of a Dehydrogenase Activity Responsible for Oxidation of 11-cis-Retinol in the Retinal Pigment Epithelium of Mice with a Disrupted RDH5 Gene. A MODEL FOR THE HUMAN HEREDITARY DISEASE FUNDUS ALBIPUNCTATUS. J. Biol. Chem.
276: 32456-32465
[Abstract]
[Full Text]
-
Liden, M., Romert, A., Tryggvason, K., Persson, B., Eriksson, U.
(2001). Biochemical Defects in 11-cis-Retinol Dehydrogenase Mutants Associated with Fundus Albipunctatus. J. Biol. Chem.
276: 49251-49257
[Abstract]
[Full Text]
-
Sieving, P. A., Chaudhry, P., Kondo, M., Provenzano, M., Wu, D., Carlson, T. J., Bush, R. A., Thompson, D. A.
(2001). Inhibition of the visual cycle in vivo by 13-cis retinoic acid protects from light damage and provides a mechanism for night blindness in isotretinoin therapy. Proc. Natl. Acad. Sci. USA
98: 1835-1840
[Abstract]
[Full Text]